City

Clinical trials near Montreal, Canada

Active studies with a listed research site in Montreal, Canada.

36active studies

23recruiting now

30countries represented

321largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Ulcerative Colitis, Obesity or OverweightCondition

Mirikizumab, MirikizumabTreatment

Austria, Belgium187 locations

Eli Lilly and CompanySponsor

Updated 2026-09-04 · NCT06937086See eligibility →

Recruiting nowPhase 3

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Crohn's Disease, Obesity or OverweightCondition

Mirikizumab, MirikizumabTreatment

Austria, Belgium183 locations

Eli Lilly and CompanySponsor

Updated 2026-09-04 · NCT06937099See eligibility →

Recruiting nowPhase 3

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Type 2 DiabetesCondition

Placebo, SurvodutideTreatment

Australia, Canada121 locations

Boehringer IngelheimSponsor

Updated 2026-09-03 · NCT07754461See eligibility →

Recruiting nowPhase 2

A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight

Obesity, OverweightCondition

BI 3034701, Placebo matching BI 3034701Treatment

Australia, Canada54 locations

Boehringer IngelheimSponsor

Updated 2026-09-03 · NCT07662122See eligibility →

Recruiting nowPhase 3

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Obesity or OverweightCondition

AZD6234, PlaceboTreatment

Argentina, Australia212 locations

AstraZenecaSponsor

Updated 2026-08-25 · NCT07784725See eligibility →

Recruiting nowPhase 1

A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant

Overweight, ObesityCondition

UBT251, Oral contraceptiveTreatment

Canada1 locations

Novo Nordisk A/SSponsor

Updated 2026-08-25 · NCT07710729See eligibility →

Recruiting nowPhase 3

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Obesity, OverweightCondition

NNC0487-0111, Placebo (matched to NNC0487-0111)Treatment

Australia, Bulgaria81 locations

Novo Nordisk A/SSponsor

Updated 2026-08-17 · NCT07509307See eligibility →

Recruiting nowPhase 2

A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)

Overweight, ObesityCondition

PF-08653945, PF-08653944Treatment

Canada, United States65 locations

PfizerSponsor

Updated 2026-08-17 · NCT07575932See eligibility →

Recruiting nowPhase 3

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Obesity or Overweight, Type 2 Diabetes MellitusCondition

Placebo, EnicepatideTreatment

Argentina, Australia193 locations

Hoffmann-La RocheSponsor

Updated 2026-08-14 · NCT07351058See eligibility →

Recruiting nowPhase 4

Fibrosis Lessens After Metabolic Surgery

Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver DiseaseCondition

Metabolic surgery, Incretin-Based TherapyTreatment

Brazil, Canada22 locations

The Cleveland ClinicSponsor

Updated 2026-07-31 · NCT06374875See eligibility →

Recruiting nowPhase 3

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Type 2 Diabetes MellitusCondition

Elecoglipron, SemaglutideTreatment

Argentina, Australia201 locations

AstraZenecaSponsor

Updated 2026-07-14 · NCT07662213See eligibility →

Recruiting nowPhase 3

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

Weight ManagementCondition

Elecoglipron, PlaceboTreatment

Argentina, Australia321 locations

AstraZenecaSponsor

Updated 2026-07-10 · NCT07667803See eligibility →

Recruiting nowPhase 2, Phase 3

A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar

Type 1 Diabetes, Type 1 Diabetes MellitusCondition

Tirzepatide, Tandem Control-IQ Automated Insulin Delivery System (with Dexcom G7 CGM)Treatment

Canada, Switzerland4 locations

McGill University Health Centre/Research Institute of the McGill University Health CentreSponsor

Updated 2026-05-27 · NCT07284511See eligibility →

Recruiting nowPhase 2

A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity

Overweight, ObesityCondition

UBT251, PlaceboTreatment

Canada, United States3 locations

Novo Nordisk A/SSponsor

Updated 2026-04-21 · NCT07395687See eligibility →

Recruiting nowNot applicable

Acute and Chronic Effects of Obesity

Obesity & Overweight, Metabolism ChangesCondition

Weight lossTreatment

Canada2 locations

Concordia University, MontrealSponsor

Updated 2026-04-07 · NCT07515547See eligibility →

Recruiting nowNot applicable

Evaluation of Cognitive Improvement After Bariatric Surgery Using a Virtual Reality Program and the Neuropsi Neuropsychological Battery

Obesity (Disorder), Obesity and Obesity-related Medical ConditionsCondition

Bariatric SurgeryTreatment

Canada, Mexico2 locations

Hospital General de México Dr. Eduardo LiceagaSponsor

Updated 2025-11-17 · NCT07229924See eligibility →

Recruiting nowNot applicable

Bone Health After Bariatric Surgery in Patients With Type 2 Diabetes

Bariatric Surgery, Bone HealthCondition

Bariatric surgeryTreatment

Canada3 locations

CHU de Quebec-Universite LavalSponsor

Updated 2025-06-10 · NCT03455868See eligibility →

Recruiting nowNot applicable

Dynamo: a Tailored Lifestyle Promotion Intervention Among Pediatric Patients With Cardiometabolic Risk Factors

ObeseCondition

Sensor based PA intervention, Traditional PA counselingTreatment

Canada1 locations

St. Justine's HospitalSponsor

Updated 2025-05-25 · NCT01736748See eligibility →

Recruiting nowPhase 3

A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes

Diabetes Type 1Condition

Intervention Period 1: Semaglutide + Empagliflozin, Intervention Period 2: Semaglutide + Empagliflozin PlaceboTreatment

Canada1 locations

McGill University Health Centre/Research Institute of the McGill University Health CentreSponsor

Updated 2025-03-30 · NCT06894784See eligibility →

Recruiting nowPhase 2, Phase 3

Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide

Type 1 Diabetes, Diabetes MellitusCondition

Semaglutide with 4 meal strategies, Placebo with 4 meal strategiesTreatment

Canada1 locations

McGill University Health Centre/Research Institute of the McGill University Health CentreSponsor

Updated 2024-12-18 · NCT06387199See eligibility →

Recruiting nowNot applicable

The Role of Nutrition in Muscle Function of Bariatric Surgery Patients

Obesity, Diabetes, Nutrition, Physical Health, Body Composition ChangesCondition

Intervention not listedTreatment

Canada1 locations

Concordia University, MontrealSponsor

Updated 2024-11-08 · NCT06680492See eligibility →

Recruiting nowNot applicable

Regional Adipose Tissue Characteristics in Type II Diabetes

Obesity and Type 2 Diabetes, Bariatric Patients Undergoing Bariatric SurgeryCondition

Intervention not listedTreatment

Canada1 locations

Concordia University, MontrealSponsor

Updated 2024-10-22 · NCT06599047See eligibility →

Recruiting nowNot applicable

TARGet Kids!: Measuring Nutrition in Young Preschool Children in the Primary Care Practice Setting

Nutritional Disorders, ObesityCondition

Intervention not listedTreatment

Canada3 locations

The Hospital for Sick ChildrenSponsor

Updated 2021-11-17 · NCT01869530See eligibility →

Opening soonPhase 3

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Obesity or Overweight, Diabetes Mellitus, Type 2Condition

AZD6234, PlaceboTreatment

Argentina, Australia218 locations

AstraZenecaSponsor

Updated 2026-08-25 · NCT07784270See eligibility →

Opening soonPhase 3

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Obesity or Overweight, Weight-Related ComorbidityCondition

AZD6234, PlaceboTreatment

Argentina, Brazil88 locations

AstraZenecaSponsor

Updated 2026-08-20 · NCT07776509See eligibility →

Opening soonPhase 4

Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss

Class I/II ObesityCondition

semaglutideTreatment

Canada1 locations

Alain DagherSponsor

Updated 2026-06-26 · NCT07592546See eligibility →

Opening soonPhase 2

Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk Adults

Type 2 Diabetes, Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)Condition

Fish Oil, Fish OilTreatment

Canada1 locations

May Faraj, PDt, PhDSponsor

Updated 2026-05-12 · NCT07575438See eligibility →

Active, not recruitingPhase 3

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes

Diabetes Mellitus, Type 2Condition

Semaglutide, Placebo (semaglutide)Treatment

Brazil, Bulgaria229 locations

Novo Nordisk A/SSponsor

Updated 2026-08-04 · NCT03811561See eligibility →

Active, not recruitingPhase 4

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

ObesityCondition

SemaglutideTreatment

Belgium, Canada93 locations

Novo Nordisk A/SSponsor

Updated 2026-06-02 · NCT06571383See eligibility →

Active, not recruitingNot applicable

MagDI Canada Study

Obesity, Type 2 DiabetesCondition

Magnet System, DI BiofragmentableTreatment

Canada3 locations

GT Metabolic Solutions, Inc.Sponsor

Updated 2026-05-20 · NCT06467955See eligibility →

Active, not recruitingPhase 3

Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

Diabetes Mellitus, Type 2Condition

Retatrutide, SemaglutideTreatment

Argentina, Canada77 locations

Eli Lilly and CompanySponsor

Updated 2026-04-13 · NCT06260722See eligibility →

Active, not recruitingPhase 3

A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight

Type 1 Diabetes, ObesityCondition

Tirzepatide, PlaceboTreatment

Argentina, Brazil79 locations

Eli Lilly and CompanySponsor

Updated 2026-02-17 · NCT06962280See eligibility →

Active, not recruitingNot applicable

Effect of Protein Source During Ketogenic Weight Loss Intervention

Obesity, Obesity; EndocrineCondition

Protein supplement - Plant protein, Protein supplement - Animal proteinTreatment

Canada1 locations

Concordia University, MontrealSponsor

Updated 2026-01-15 · NCT06461806See eligibility →

Active, not recruitingPhase 3

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

Type 2 Diabetes Mellitus (T2DM), Obesity, OverweightCondition

Maridebart cafraglutide, PlaceboTreatment

Argentina, Bulgaria187 locations

AmgenSponsor

Updated 2025-12-31 · NCT06858878See eligibility →

Active, not recruitingPhase 4

A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes

Type 2 DiabetesCondition

Tirzepatide, Antihyperglycemic medicationTreatment

Argentina, Canada90 locations

Eli Lilly and CompanySponsor

Updated 2025-12-12 · NCT05433584See eligibility →

Active, not recruitingNot applicable

Fit-for-Fertility Multicenter Randomized Controlled Trial

Obesity, Infertility, FemaleCondition

Fit-For-Fertility program, Standard of careTreatment

Canada5 locations

Université de SherbrookeSponsor

Updated 2025-03-19 · NCT03908099See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Montreal, Canada

Current studies

Related cities